These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37 related articles for article (PubMed ID: 15479125)
1. Gender differences in plasma levels of lipoprotein (a) in patients with angiographically proven coronary artery disease. Frohlich J; Dobiásová M; Adler L; Francis M Physiol Res; 2004; 53(5):481-6. PubMed ID: 15479125 [TBL] [Abstract][Full Text] [Related]
2. No association between plasma lipoprotein(a) concentrations and the presence or absence of coronary atherosclerosis in African-Americans. Moliterno DJ; Jokinen EV; Miserez AR; Lange RA; Willard JE; Boerwinkle E; Hillis LD; Hobbs HH Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):850-5. PubMed ID: 7600116 [TBL] [Abstract][Full Text] [Related]
3. [Distribution and influencing factors of lipoprotein (a) levels in non-arteriosclerotic cardiovascular disease population in China]. Ke YL; Pan L; Lyu J; Sun DJY; Pei P; Chen YP; Yang L; Du HD; Clarke R; Chen JS; Chen ZM; Zhang X; Chen T; Li RQ; Qi LT; Li LM; Yu CQ Zhonghua Liu Xing Bing Xue Za Zhi; 2024 Jun; 45(6):779-786. PubMed ID: 38889976 [No Abstract] [Full Text] [Related]
4. Synergistic and Non-synergistic Associations for Cigarette Smoking and Non-tobacco Risk Factors for Cardiovascular Disease Incidence in the Atherosclerosis Risk In Communities (ARIC) Study. Lubin JH; Couper D; Lutsey PL; Yatsuya H Nicotine Tob Res; 2017 Jul; 19(7):826-835. PubMed ID: 27651477 [TBL] [Abstract][Full Text] [Related]
5. Can Plaque Imaging Improve Risk Assessment Among Individuals With Elevated Lp(a)? Blankstein R; Shiyovich A J Am Coll Cardiol; 2024 May; 83(18):1756-1759. PubMed ID: 38692828 [No Abstract] [Full Text] [Related]
6. Prediction of cardiovascular risk factors and metabolic syndrome in adults from Saudi Arabia using the logarithm of triglyceride/HDL-cholesterol ratio. Althwab SA; Abdulmonem WA; Allemailem KS; Alarifi SA; Hamad EM Int J Health Sci (Qassim); 2024; 18(2):50-55. PubMed ID: 38455599 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment. Lampsas S; Xenou M; Oikonomou E; Pantelidis P; Lysandrou A; Sarantos S; Goliopoulou A; Kalogeras K; Tsigkou V; Kalpis A; Paschou SA; Theofilis P; Vavuranakis M; Tousoulis D; Siasos G Molecules; 2023 Jan; 28(3):. PubMed ID: 36770634 [TBL] [Abstract][Full Text] [Related]
8. Long-term prognostic value of LDL-C, HDL-C, lp(a) and TG levels on cardiovascular disease incidence, by body weight status, dietary habits and lipid-lowering treatment: the ATTICA epidemiological cohort study (2002-2012). Georgoulis M; Chrysohoou C; Georgousopoulou E; Damigou E; Skoumas I; Pitsavos C; Panagiotakos D Lipids Health Dis; 2022 Dec; 21(1):141. PubMed ID: 36529737 [TBL] [Abstract][Full Text] [Related]
9. Correlations Between Coronary Artery Disease, Coronary Artery Calcium Score, and Lipoprotein(a) Level in Korea. Kim J; Choi SW; Lee YS; Lee JM; Chung H; Woo JS; Kim WS; Choi YY; Kim W Ther Clin Risk Manag; 2022; 18():981-987. PubMed ID: 36212048 [TBL] [Abstract][Full Text] [Related]
11. Performance evaluation of five lipoprotein(a) immunoassays on the Roche cobas c501 chemistry analyzer. Wyness SP; Genzen JR Pract Lab Med; 2021 May; 25():e00218. PubMed ID: 33898688 [TBL] [Abstract][Full Text] [Related]
12. Relationship between Lipoprotein (a) and cognitive function - Results from the Berlin Aging Study II. Röhr F; Bucholtz N; Toepfer S; Norman K; Spira D; Steinhagen-Thiessen E; Lill CM; Bertram L; Demuth I; Buchmann N; Düzel S Sci Rep; 2020 Jun; 10(1):10636. PubMed ID: 32606300 [TBL] [Abstract][Full Text] [Related]
13. Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule. Jawi MM; Frohlich J; Chan SY J Lipids; 2020; 2020():3491764. PubMed ID: 32099678 [TBL] [Abstract][Full Text] [Related]
15. Differential Effects of Continuous and Interval Exercise Training on the Atherogenic Index of Plasma in the Non-Obese Young Male. Ezeukwu AO; Agwubike EO; Uadia PO Acta Cardiol Sin; 2015 Jul; 31(4):337-44. PubMed ID: 27122890 [TBL] [Abstract][Full Text] [Related]
16. Lipoprotein(a) and Increased Cardiovascular Risk in Women. Costello BT; Silverman ER; Doukky R; Braun LT; Aggarwal NT; Deng Y; Li Y; Lundberg G; Williams KA; Volgman AS Clin Cardiol; 2016 Feb; 39(2):96-102. PubMed ID: 26880352 [TBL] [Abstract][Full Text] [Related]
17. Lipoprotein (a): impact by ethnicity and environmental and medical conditions. Enkhmaa B; Anuurad E; Berglund L J Lipid Res; 2016 Jul; 57(7):1111-25. PubMed ID: 26637279 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein (a): structure, pathophysiology and clinical implications. Maranhão RC; Carvalho PO; Strunz CC; Pileggi F Arq Bras Cardiol; 2014 Jul; 103(1):76-84. PubMed ID: 25120086 [TBL] [Abstract][Full Text] [Related]
19. Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort. Allard MD; Saeedi R; Yousefi M; Frohlich J Lipids Health Dis; 2014 Apr; 13():65. PubMed ID: 24712315 [TBL] [Abstract][Full Text] [Related]
20. Lipoprotein(a) is strongly associated with coronary artery calcification in type-2 diabetic women. Qasim AN; Martin SS; Mehta NN; Wolfe ML; Park J; Schwartz S; Schutta M; Iqbal N; Reilly MP Int J Cardiol; 2011 Jul; 150(1):17-21. PubMed ID: 20303190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]